Endpoints News ٢٨ يناير ٢٠٢٦ HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launch
Endpoints News ٢٨ يناير ٢٠٢٦ Boehringer Ingelheim takes rare kidney disease drug to Phase 3 despite puzzling mid-stage data
Endpoints News ٢٧ يناير ٢٠٢٦ CMS picks Lilly’s Trulicity, Gilead's Biktarvy for third round of Medicare negotiations
Endpoints News ٢٧ يناير ٢٠٢٦ Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma